{"id":"https://openalex.org/W2001191114","doi":"https://doi.org/10.1016/0922-4106(95)90073-x","title":"NS-49, a novel \u03b11a-adrenoceptor-selective agonist characterization using recombinant human \u03b11-adrenoceptors","display_name":"NS-49, a novel \u03b11a-adrenoceptor-selective agonist characterization using recombinant human \u03b11-adrenoceptors","publication_year":1995,"publication_date":"1995-11-01","ids":{"openalex":"https://openalex.org/W2001191114","doi":"https://doi.org/10.1016/0922-4106(95)90073-x","mag":"2001191114","pmid":"https://pubmed.ncbi.nlm.nih.gov/8719417"},"language":"en","primary_location":{"id":"doi:10.1016/0922-4106(95)90073-x","doi":"https://doi.org/10.1016/0922-4106(95)90073-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0922-4106(95)90073-x","pdf_url":null,"source":{"id":"https://openalex.org/S4210192051","display_name":"European Journal of Pharmacology Molecular Pharmacology","issn_l":"0922-4106","issn":["0922-4106","1872-8251"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology: Molecular Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030523007","display_name":"Kenji Obika","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kenji Obika","raw_affiliation_strings":["Department of Molecular, Cell Pharmacology, National Children's Medical Research Center, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular, Cell Pharmacology, National Children's Medical Research Center, Tokyo, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112324241","display_name":"Katsushi Shibata","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katsushi Shibata","raw_affiliation_strings":["Department of Molecular, Cell Pharmacology, National Children's Medical Research Center, 3-35-31 Taishido, Setagaya-ku, Tokyo, 154 Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular, Cell Pharmacology, National Children's Medical Research Center, 3-35-31 Taishido, Setagaya-ku, Tokyo, 154 Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109087600","display_name":"Kuniko Horie","orcid":"https://orcid.org/0000-0003-0053-5091","observed_orcids":["https://orcid.org/0000-0003-0053-5091"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kuniko Horie","raw_affiliation_strings":["Department of Molecular, Cell Pharmacology, National Children's Medical Research Center, 3-35-31 Taishido, Setagaya-ku, Tokyo, 154 Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular, Cell Pharmacology, National Children's Medical Research Center, 3-35-31 Taishido, Setagaya-ku, Tokyo, 154 Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029764450","display_name":"Rudolf Foglar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rudolf Foglar","raw_affiliation_strings":["Department of Molecular, Cell Pharmacology, National Children's Medical Research Center, 3-35-31 Taishido, Setagaya-ku, Tokyo, 154 Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular, Cell Pharmacology, National Children's Medical Research Center, 3-35-31 Taishido, Setagaya-ku, Tokyo, 154 Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101912431","display_name":"Kiyoshi Kimura","orcid":"https://orcid.org/0000-0002-9036-403X","observed_orcids":["https://orcid.org/0000-0002-9036-403X"]},"institutions":[{"id":"https://openalex.org/I4210162696","display_name":"Nippon Shinyaku (Japan)","ror":"https://ror.org/05wyn3p10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210162696"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kiyoshi Kimura","raw_affiliation_strings":["The Research Laboratories, Nippon Shinyaku Co., Ltd., Nishiohji Hachijyo, Minami-ku, Kyoto, 601 Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Research Laboratories, Nippon Shinyaku Co., Ltd., Nishiohji Hachijyo, Minami-ku, Kyoto, 601 Japan","institution_ids":["https://openalex.org/I4210162696"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5105686750","display_name":"Gozoh Tsujimoto","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Gozoh Tsujimoto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5105686750"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3112,"has_fulltext":false,"cited_by_count":28,"citation_normalized_percentile":{"value":0.47023906,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"291","issue":"3","first_page":"327","last_page":"334"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alpha1a-adrenoceptor","display_name":"alpha1A-adrenoceptor","score":0.8479999899864197},{"id":"https://openalex.org/keywords/alpha1-adrenoceptor-subtypes","display_name":"alpha1-adrenoceptor subtypes","score":0.8939999938011169},{"id":"https://openalex.org/keywords/oxymetazoline","display_name":"oxymetazoline","score":0.9150000214576721},{"id":"https://openalex.org/keywords/partial-agonists","display_name":"partial agonists","score":0.8379999995231628},{"id":"https://openalex.org/keywords/receptor-subtype-selectivity","display_name":"receptor subtype selectivity","score":0.75},{"id":"https://openalex.org/keywords/radioligand-binding-affinity","display_name":"radioligand binding affinity","score":0.8100000023841858},{"id":"https://openalex.org/keywords/intracellular-calcium-response","display_name":"intracellular calcium response","score":0.7429999709129333},{"id":"https://openalex.org/keywords/imidazoline-agonists","display_name":"imidazoline agonists","score":0.8019999861717224}],"concepts":[{"id":"https://openalex.org/C2780042274","wikidata":"https://www.wikidata.org/wiki/Q417813","display_name":"Oxymetazoline","level":4,"score":0.9682070016860962},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.7841108441352844},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.7604422569274902},{"id":"https://openalex.org/C64943373","wikidata":"https://www.wikidata.org/wiki/Q2651003","display_name":"Alpha (finance)","level":4,"score":0.6158633232116699},{"id":"https://openalex.org/C175656101","wikidata":"https://www.wikidata.org/wiki/Q56646","display_name":"Chinese hamster ovary cell","level":3,"score":0.5923386812210083},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5585734248161316},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.44618338346481323},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4319920241832733},{"id":"https://openalex.org/C13348194","wikidata":"https://www.wikidata.org/wiki/Q288084","display_name":"Alpha-2 adrenergic receptor","level":3,"score":0.4297093152999878},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3753699064254761},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.3527997136116028},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3451223075389862},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.30398860573768616},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2505173683166504},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1962169110774994},{"id":"https://openalex.org/C49453240","wikidata":"https://www.wikidata.org/wiki/Q1592163","display_name":"Construct validity","level":3,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0},{"id":"https://openalex.org/C2775944032","wikidata":"https://www.wikidata.org/wiki/Q22907659","display_name":"Patient satisfaction","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000316","descriptor_name":"Adrenergic alpha-Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000317","descriptor_name":"Adrenergic alpha-Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000813","descriptor_name":"Anilides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002118","descriptor_name":"Calcium","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006224","descriptor_name":"Cricetinae","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009638","descriptor_name":"Norepinephrine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010109","descriptor_name":"Oxymetazoline","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010656","descriptor_name":"Phenylephrine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D016466","descriptor_name":"CHO Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018340","descriptor_name":"Receptors, Adrenergic, alpha-1","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D018340","descriptor_name":"Receptors, Adrenergic, alpha-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/0922-4106(95)90073-x","doi":"https://doi.org/10.1016/0922-4106(95)90073-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0922-4106(95)90073-x","pdf_url":null,"source":{"id":"https://openalex.org/S4210192051","display_name":"European Journal of Pharmacology Molecular Pharmacology","issn_l":"0922-4106","issn":["0922-4106","1872-8251"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology: Molecular Pharmacology","raw_type":"journal-article"},{"id":"pmid:8719417","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8719417","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of pharmacology","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.5683000087738037}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320309773","display_name":"Japan Health Sciences Foundation","ror":"https://ror.org/04z7xfj55"},{"id":"https://openalex.org/F4320317858","display_name":"Nippon Shinyaku","ror":"https://ror.org/05wyn3p10"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W1533437922","https://openalex.org/W1586068082","https://openalex.org/W1841809633","https://openalex.org/W1865252654","https://openalex.org/W1870803056","https://openalex.org/W1922812725","https://openalex.org/W1966176869","https://openalex.org/W2014747325","https://openalex.org/W2020404323","https://openalex.org/W2021419143","https://openalex.org/W2025346855","https://openalex.org/W2032247634","https://openalex.org/W2033653650","https://openalex.org/W2043813981","https://openalex.org/W2084330407","https://openalex.org/W2090443003","https://openalex.org/W2092532253","https://openalex.org/W2094806500","https://openalex.org/W2141260882","https://openalex.org/W2172313765","https://openalex.org/W2271473641","https://openalex.org/W2287804847","https://openalex.org/W2289078098","https://openalex.org/W2401452038","https://openalex.org/W2410581522","https://openalex.org/W2418498003","https://openalex.org/W2422010622","https://openalex.org/W2468701614","https://openalex.org/W4416702861"],"related_works":["https://openalex.org/W2032247634","https://openalex.org/W3100358238","https://openalex.org/W1922812725","https://openalex.org/W2041940726","https://openalex.org/W3196575273","https://openalex.org/W2155788147","https://openalex.org/W3105637136","https://openalex.org/W2368108799","https://openalex.org/W3101900839","https://openalex.org/W1967479412"],"abstract_inverted_index":null,"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}